SlideShare a Scribd company logo
1 of 73
Clinico pathologic conference
Bengaluru Neurological Society
Presenter: Dr Pramod Krishnan
Consultant Neurologist
Manipal Hospital, Bengaluru
May 2017
Initial presentation
Chief complaints
• 48yr/ male, farmer from West Bengal.
• Apparently normal till January 2017. Since then:
1. Holocranial throbbing headache
2. Mild intermittent fever
3. Bilateral painless impairment in vision (April 2017)
History of presenting illness: fever
• First seen at NIMHANS on 13.05.17.
• Fever from January 2017, mild, intermittent, and usually in the
form of an evening rise of temperature.
• The fever used to subside with anti-pyretics with mild sweating.
There were no chills or rigors.
Headache
• Headache was holocranial, worse in the occipital and neck region.
• It was intermittent and throbbing in nature.
• It was not associated with vomiting.
• There was no specific diurnal or postural change.
Impairment of vision
• From April 2017, developed bilateral painless impairment in vision.
• It was worse in the right as compared to the left eye.
• The onset was not clear, but there was no progression from the
time it was noted.
• There was intermittent redness of the eyes (? no pain).
• There was no excessive lacrimation or diplopia.
History of presenting illness
• No symptoms referable to other cranial nerves or limbs.
• No band-like sensation, inco-ordination of limbs, involuntary
movements, cognitive decline, seizures or altered sensorium.
• No history of skin rash, pain or swelling of joints, photosensitivity,
muco-cutaneous ulcers, diabetes mellitus or hypertension.
• No significant past medical history.
Personal and family history
• Mixed diet
• No change in appetite or weight loss.
• No substance use.
• He had contact with cattle, but denied handling placental products
or raw milk.
• No family history of tuberculosis.
Treatment history
• He was diagnosed as TBM at another centre and was on treatment
from 6th May 2017 (HRZE and 20mg/d prednisolone).
Analysis
Fever
• Fever, low grade, lasting 5 months is most likely due to
inflammatory conditions (infectious, non-infectious) but may
occur with non-inflammatory conditions like neoplasms.
• No significant systemic symptoms or weight loss.
Headache
• Headache since 5 months is diffuse, poorly localised, persistent,
and consistent with a secondary headache.
• To consider an intracranial pathology in view of the poorly
localised deep seated pain.
• Cause could be inflammation, raised ICP or lesions causing
stretch, compression, or infiltration of pain-sensitive structures.
Headache
• No history to suggest raised ICP as the cause of headache, such as
pain worse on awakening, coughing/straining, activity, or
associated vomiting, tinnitus, dizziness, TVO.
• Headache is worse in the occipital and neck region, indicating
involvement of posterior fossa structures, meninges.
• Meningeal pathology causes non-localising headache, with or
without raised ICP features.
Visual impairment
• Bilateral (asymmetric) painless loss of vision (non-progressive):
1. Bilateral optic neuropathies: inflammatory, ischemic, toxic.
2. Papilledema
3. Lesions of optic chiasma, less often, optic tracts.
4. Occipital stroke, bilateral
5. Pituitary apoplexy.
6. Trauma
7. Functional visual loss.
Causes of Red eye Remarks
Corneal abrasions Trauma, Vth or VIIth nerve palsy.
Subconjunctival hemorrhage Spontaneous, trauma, coughing, bleeding diathesis.
Pingueculitis Inflammation of pinguecula, a small, raised nodule at the temporal or nasal
limbus.
Dacryocystitis Obstruction of the lacrimal system.
Conjunctivitis Infectious (viral, allergic).
Keratitis Trachoma, HSV, VZV, other bacterial and fungal infection, Vit A def.
Keratoconjunctivits sicca Drugs, Sarcoidosis, Sjogren, radiation, VIIth nerve palsy.
Episcleritis Idiopathic > autoimmune.
Scleritis Usually autoimmune: RA, SLE, PAN, Wegeners, relapsing polychondritis.
Anterior uveitis (iridocyclitis) Sarcoidosis, AS, JRA, IBD, psoriasis, Reiter’s, Behcets, TB, leprosy,
Lymes, syphilis, herpes, onchocerciasis.
Posterior uveitis Sarcoidosis, Behcets, VGH, IBD, bacterial, fungal, spirochetal and
mycobacterial infections.
Endophthalmitis Bacterial, fungal, viral, parasitic infections.
Acute angle closure glaucoma
Provisional diagnosis
1. Chronic infectious meningitis: TB, Brucella, fungal
2. Chronic non-infectious meningeal inflammation: vasculitis
3. Slowly progressive diffuse intracranial neoplasm.
• Raised ICP due to either of these pathologies to be considered.
• Wide range of infectious etiology to be considered as patient could
be immunocompromised.
Clinical examination
• He was conscious, alert, and oriented.
• General physical examination was normal.
• Visual acuity was 6/9 and 6/12 in the right and left eyes
respectively.
• Optic fundi were normal. Other cranial nerves were normal.
• Motor system, sensory system, DTRs, were normal.
• Plantar response was flexor bilaterally.
• There were no meningeal signs.
Analysis
• No papilledema, therefore headache and visual impairment is
unlikely due to raised ICP.
• Bilateral visual impairment with normal fundi and EOMS
indicates inflammatory, infiltrative or ischemic pathology involving
optic chiasma/ optic nerves.
Provisional diagnosis
• Structures involved:
1. Meninges
2. Optic chiasma and adjoining posterior portions of both the optic
nerves/ tracts.
3. ?Uveitis/ keratoconjnctivitis
• Pathology:
1. Chronic infectious meningitis
2. Chronic non-infectious meningeal inflammation
3. Slowly progressive diffuse intracranial neoplasm.
Uveo-meningitis
Sarcoidosis Primary angiitis of CNS.
Vogt-Koyanagi-Harada syndrome Syphilis
Primary CNS lymphoma Lyme disease
Behcets syndrome HTLV type 1 infection
SLE Acute multifocal placoid pigmentary epitheliopathy
Course of his illness
CSF analysis (done elsewhere)
• Confirms meningeal pathology,
most likely inflammation.
• 5 months into his illness,
protein elevation is mild
(unusual for TB and other
infections), with lymphocytic
pleocytosis.
• Primary leptomeningeal
neoplasm can mimic
tuberculosis.
Parameter May 17*
Appearance
Cell count (/cu mm) 102
Cell type L- 70%
P- 30%
CSF protein (mg/dl) 74
CSF glucose (mg/dl) 42
CSF Chloride (mmol/L) NA
CSF Lactate (mg/dl) NA
Gram stain
India Ink NA
Cryptococcal Ag
Bacterial culture
AFB culture
Course of his illness
• In view of visual impairment, ATT was modified.
• Ethambutol was stopped and streptomycin (750 mg/ day, IM) and
ofloxacin (800 mg/ day) were introduced.
• The dose of oral prednisolone was increased to 60 mg/ day.
July 2017
Course of his illness
• Fever subsided from June 2017.
• Headache reduced partially. There was minimal change in vision.
• Developed impaired hearing in the left ear from June 2017.
• There was no local pain, swelling or ear discharge.
• AC > BC in the right ear, and Weber’s test showed lateralisation to
the right ear; the patient could not perceive the sound of the
tuning fork by air or bone conduction in the left ear (left SNHL).
• There were no other new neurological deficits.
Comment
• Improvement in headache and fever could be due to ATT, or more
likely due to steroids.
• Inspite of therapy, vision did not improve and he developed left
sided sensori neural deafness, suggesting left VIIIth nerve
involvement.
August 2017
Parameter May 17* Aug 2017
Appearance Clear
Cell count (/cu mm) 102 115
Cell type L- 70%
P- 30%
L- 70%
P- 29%
Degenerative
cells 1%
CSF protein (mg/dl) 74 47
CSF glucose (mg/dl) 42 47
CSF Chloride
(mmol/L)
NA NA
CSF Lactate (mg/dl) NA NA
Gram stain
India Ink NA Negative
Cryptococcal Ag
Bacterial culture
AFB culture No growth
Parameter May 17 Aug 2017
Gene Xpert
Cytospin Transformed
lymphocytes,
admixed with
reactive
monocytes and
RBCs. Few
PMN cells are
also seen
VDRL Non-reactive
Xcyton panel
CSF Analysis
No significant improvement except
for drop in protein levels.
Course of his illness
• Streptomycin and pyrazinamide were discontinued in August 2017.
Isoniazid, rifampicin and ofloxacin were continued along with oral
prednisolone (60 mg/day).
• He also developed cushingoid facies by August 2017.
November 2017
Course of the illness
• Recurrence of fever from November 2017, which was mild,
intermittent and usually in the morning. This was not associated
with night sweats, loss of appetite or weight loss.
• Headache increased in frequency and intensity, was frontal in
location and used to resolve spontaneously in 5 to 10 minutes.
• He also developed diabetes mellitus which was treated.
2018
Course of his illness
• Isoniazid, rifampicin and ofloxacin were continued.
• Prednisolone was tapered from January 2018 by 5 mg every 15 days
to 5 mg/ day by July 2018.
• The patient developed neck pain from mid-July 2018 along with left
hemicranial headache.
• Isoniazid and rifampicin were continued. Ofloxacin was
discontinued in November 2018.
2019
Course of his illness
• Ethambutol (800 mg/ day) and Moxifloxacin (400 mg/ day) were
added.
• Oral prednisolone was increased to 60 mg/ day.
• However, there was progressive increase in headache, mainly in
the neck and vertex region.
• Hence he underwent biopsy of meninges on 14th March 2019.
• Based on the biopsy he was initiated on treatment. He was
discharged on 20th March 2019. There is no further follow up.
Test 27/July/17 12/Nov/18 28/Feb/19 13/Mar/19 14/Mar/19 16/Mar/19
Hb (ref: 13-17 gm/dl) 15.4 16.0 14.1
Haematocrit (ref: 40-50%) 45.2%
MCH (ref: 27-32 pg) 30.5
MCHC (31.5-34.5 g/dl) 34.0
MCV (ref: 83-101 fl) 89.7
TLC (ref: 4-11K/ µl) 10.5 13.4 11.4
Differential count N=52.2%,
L=36.3%, M=6.3%,
E=4.8%, B=0.4%
N=75.2%,
L=14.1%,
M=9.4%,
E=0.4%,
B=0.9%
Platelets (ref: 150-450K/µl) 82 207 207
ESR (ref: 0-10 mm/hr) 9 20 20 80
Peripheral smear Normal except for
several large
platelets seen. No
hemoparasites.
Hematology
Tests 27/July/17 30/ Jan/ 18 5/ Nov/ 18 28/ Feb/ 19 13/ Mar/ 19 14/ Mar/ 19
RBS (mg/dl) (ref: 70-140 mg/ dL) 90 324 70
FBS (mg/dl) (ref: 70-100 mg/ dL) 161
PPBS (mg/dl) (ref: 100-140 mg/dl) 322
Urea (mg/dl) 15 16 18.0 20.0
Creatinine (mg/dl) 0.91 0.78 0.8 0.8
T Protein (g/dL) (ref: 5.7-8.0 g/ dL) 6.6 6.20 6.60
Albumin (g/dL) (ref: 3.5-5.2 g/ dL) 3.86 4.00 3.90
Globulin (g/dL) (ref: 2.5-5.6 g/ dL) 2.7 2.20 2.70
A:G Ratio (ref: 1.2-2.5) 1.4 1.80 1.40
Total Bilirubin (mg/dl) 0.90 0.34 0.75
ALP (U/L) (ref: 52-171 U/ L) 106 102 70
SGOT (U/L) (ref: 8-50 U/ L) 92 14.0 33.0
SGPT (U/L) (ref: 7-50 U/ L) 240 30.0 36.0
Sodium (mEq/L) 139.4 141.00 140.0 137.2
Potassium (mEq/L) 4.21 3.92 4.18 3.82
Chloride (mEq/L) 100.2 98 104.2 107.2
Homocysteine (ref:<15micromol/L) 12.9
Vitamin B12 (ref: 197-771 pg/ml) 257
Biochemistry
Parameter May 17* Aug 2017 Sept 2018 Nov 18 Jan 2019 Mar 2019
Appearance Clear Clear Hazy Slightly hazy
Cell count (/cu mm) 102 115 350 140 1000 120
Cell type L- 70%
P- 30%
L- 70%
P- 29%
Degenerative
cells 1%
L- 80%
Degenerated cells-
20%
Occasional RBCs
L- 70%
P- 30%
L- 20%
P- 80%
Occasional
RBCs
L- 20%
P- 75%
Degenerative cells
5%
CSF protein (mg/dl) 74 47 155 105 338 177
CSF glucose (mg/dl) 42 47 73 175 297 216
CSF Chloride
(mmol/L)
NA NA 120 119 114 119
CSF Lactate (mg/dl) NA NA NA 28 NA NA
Gram stain Pus cells. No
bacteria
Pus cells. No
bacteria
India Ink NA Negative Negative NA Negative Negative
Cryptococcal Ag Negative
Bacterial culture No growth
AFB culture No growth No growth No growth
CSF analysis
* reported from another centre.
Parameter May 17 Aug 2017 Sept 2018 Nov 18 Jan 2019 Mar 2019
Gene Xpert Insufficient sample Negative Negative
Cytospin Transformed
lymphocytes,
admixed with
reactive
monocytes and
RBCs. Few
PMN cells are
also seen
Transformed
lymphocytes, few
reactive monocytes,
PMN cells &
RBC's.
Predominantly
PMN cells, few
lymphocytes,
occasional
reactive
monocytes,
eosinophils &
plasmacytoid
cells.
Numerous
degenerating
PMN cells, few
intermixed
reactive
lymphocytes and
monocytoid cells.
VDRL Non-reactive Non-reactive
Xcyton panel Positive for
cysticercal
antibody
CSF analysis
Chronic meningitis with neutrophilis in CSF
Infections Non-infectious
Tuberculosis SLE
Brucella Chemical meningitis: craniopharyngioma
Nocardia asteroides Adult Stills disease
Actinomyces israeli Primary CNS angiitis.
Cysticercal meningitis
Fungi: Blastomyces dermatitidis, Candida albicans, Histoplasma capsulatum,
Aspergillus spp, Pseudallescheria boydii, Cladophialophora bantiana.
Cysti-CheX test for cysticercosis (Xcyton)
• Semi-quantitative ELISA for detecting antibodies to cysticercal E-
S antigens.
• It uses Secretory and Excretory antigens of cysticerci (E-S
antigen).
• These antigens are very specific and immunogenic.
• Sensitivity and specificity of the test is close to 100% (Neurological
practice: an Indian perspective. 2015. Ed Noshir H Wadia, Satish V Khadilkar)
Other investigations Results
TFT Normal
ANA, ANA profile, ANCA, RA Negative
ACE level Normal
PT, APTT Normal
HIV, S. VDRL Non reactive
Blood culture No growth
HbA1c 8.8% (Jan 2018), 15.6% (March 2019)
Serum paraneoplastic antibody panel GAD65 positive (1+)
Brucella Standard Agglutination Test Negative
Absolute CD4 count 1856 /ul
Anti GAD 65 positivity
Stiff person syndrome Hashimotos thyroiditis
Autoimmune encephalitis Pernicious anemia
Brain stem encephalitis Type 1 diabetes.
Cerebellar ataxia syndromes Myelitis
Myasthenia gravis Miller Fischer syndrome like presentation
Lambert Eaton syndrome Autoimmune encephalitis
Positive GAD 65 antibody may suggest an autoimmune process in this patient.
Audiometry (23/8/17): right ear normal. Left ear shows severe
sensori neural deafness.
July 2017 November 2018
Right eye Inferior altitudinal scotoma Normal
Left eye Normal Normal
Visual field charting:
VEP: P100 latency- 107.7 ms (Rt), 106.5 ms (lt): upper limit of
normal.
SSEP of median and posterior tibial nerves: Normal
BAER I II III IV V I-III III-V I-V
Right ear 1.45 2.76 3.74 4.98 5.96 2.29 2.22 4.51 Normal
Left ear 2.39 5.57 7.13 4.74 Delayed.
Radiology
September 2018
MRI brain 3D post-contrast T1W axial sequence shows few enhancing nodules along tentorium and
meninges.
MRI brain post contrast T1W axial sequence shows dural enhancement along prepontine cistern and
seventh nerve in left IAC (left) and focal enhancing nodule along pial surface of medulla (right).
MRI upper cervical cord post contrast T1W sequence axial (left) and sagittal (right) showing tiny
enhancing foci along surface of cervical cord.
MRI brain post contrast T2flair axial sequences show lepto-meningeal enhancement in the basal
cisterns.
March 2019
MRI cervical spine coronal and axial post contrast of cervical spine shows nodular dural
enhancement in upper cervical cord on right side .There is also enhancement along left cervical
nerve roots.
MRI brain post contrast T1W axial sequence shows Persistence of dural enhancement along pre-
pontine cistern and left seventh nerve.
MRI brain post contrast T1W axial sequence shows leptomeningeal enhancement along lateral and
posterior surface of brainstem.
MRI brain post contrast flair shows increased leptomeningeal enhancement in basal cisterns and
interval appearance of leptomeningeal enhancement in right posterior Sylvian fissure.
MRI brain fiesta images shows right half of chiasm, optic tract showing increased signal. There
is also absent CSF plane with adjacent structures ? Septations. No post contrast enhancement.
Summary of MRI images
• Leptomeningeal nodular patchy enhancement involving basal
cisterns, optic chaisma and around the cervical cord and roots,
with adhesions.
• No parenchymal involvement at the end of 2 years.
• Small areas of dural involvement noted in the cervico medullary
junction.
• Definite increase in lesions while on treatment.
• Possibilities are granulomatous leptomeningeal disease > primary
leptomeningeal neoplasm.
Other radiological investigations
• CT thorax (twice): unremarkable.
• CT brain: unremarkable. No calcification.
• X ray chest: unremarkable.
• X ray cervical spine: unremarkable.
• USG abdomen: normal.
The Last Lap!!
Summary
• Chronic meningeal disease of > 2 years duration, with fever.
• No response to ATT, clinically or based on CSF, MRI.
• Partial benefit with steroids, with worsening on steroid reduction,
but some worsening occurred while on 60 mg/d prednisolone.
• Nodular patchy leptomeningeal enhancement on MRI involving
basal cisterns, surface of medulla and cervical cord, roots, sylvian
fissure, with dural involvement and adhesions and without
parenchymal involvement.
• CSF shows lymphocytic pleocytosis with mild elevation of proteins
and later shows predominance of PMNs and counts >1000 cells.
Bacterial and parasitic infections
Disease Points in favour Points against
Tuberculosis Neutrophilic CSF pleocytosis can occur,
(but usually early in the disease).
Leptomeningeal disease of 2 years with
fever and headache can occur.
?MDR TB.
No parenchymal involvement.
No systemic symptoms.
No response to ATT
Gene X pert repeatedly negative
Only mild elevation of CSF
protein
Cysticercal
meningitis
Xcyton cysticercal test positive in CSF.
Partial response to steroids.
Involvement of basal cisterns, adhesions.
Neutrophils in CSF and cell count of >1000
are described in this condition.
No cysts seen in the basal
cisterns.
No CSF pathway obstruction
seen.
• 138/336 pts (41%) had parasites in the subarachnoid space at the base of the brain.
• Group A had a mean ± SD disease duration of 36.33 ± 13.4 months, and Group B had a
mean ± SD disease duration of 15.6 ± 1.91 months.
• Group A had increased neutrophils with a mean ± SD of 2,158 ± 475.78 cells/cumm.
14 patients in this series presented as chronic meningitis.
Clinical Infectious Diseases 2013;56(10):1407–12
The sensitivity of tube agglutination (TA) in CSF was 0.94, specificity 0.96, positive
predictive value 0.94, and negative predictive value 0.96.
Points in favor Points against
Rifampicin, Streptomycin are effective
treatment for Brucellosis
No musculoskeletal disease or brain
parenchymal disease at the end of 2 years.
Can present as chronic meningitis. Brucella antibody test is negative
h/o contact with cattle. CSF cell count of 1000 is not reported.
Neutrophils in CSF may be seen.
Chronic fungal/ Nocardia meningitis
• Some of these organisms are ubiquitous and endemic in parts of
India, but others are very rarely reported.
• CSF neutrophils can be seen.
• However, more common in immunocompromised patients.
• No appropriate exposure history.
• Absence of brain parenchymal lesions, parameningeal focus, sino-
pulmonary disease over 2 years, while on steroids is odd.
• Usually cause complicated meningitis.
Wegeners granulomatosis
Points in favour Points against
Nodular leptomeningeal enhancement.
Dural involvement.
Isolated CNS disease is possible.
Intermittent red eye.
CSF can show neutrophils
Poor response to steroids alone is
possible as it requires aggressive
immunosuppression.
No sinus or pulmonary disease.
Usually causes pachymeningitis.
ANCA negative.
CSF cell count of 1000 is rare.
Neurosarcoidosis
Points in favour Points against
Isolated neurosarcoidosis is well
known.
Cranial neuropathy (II, VIII).
Partial response to steroids.
Possible uveitis (red eye).
CT thorax normal (twice).
ACE levels normal.
CSF neutrophils not reported.
Steroids are the mainstay of treatment, so
response should have been better.
CSF cell count of 1000 is unlikely.
• 10/91 patients with neurosarcoidosis had isolated neuro-sarcoidosis.
• Common clinical manifestations: headache (9), paresthesia (5), and cranial
neuropathies (4).
• No extraneural sarcoidosis developed during a long follow-up period (mean 58 mo).
• Compared with those who also had systemic neurosarcoidosis, isolated
neurosarcoidosis patients had a more common frequency of headache, hemiparesis,
and radiculopathy, leptomeningeal involvement on brain MRI, increased cell count in
cerebrospinal fluid, and a more favorable clinical outcome (P < 0.05).
The Neurologist 2012; 18:373–377)
Disease Points in favour Points against
SLE, Sjogrens CSF neutrophils is
reported.
Possible uveitis.
ANA, ANA profile negative.
Very high cell counts is not reported.
Absence of brain parenchymal disease or
systemic disease.
Inadequate response to steroids.
Behcets disease Possible uveitis. Usually a recurrent meningitis.
No oro-genital ulcers.
CSF neutrophils, very high cell counts not
reported.
SLE, Behcets disease, Primary CNS angiitis
Primary CNS angiitis is unlikely as the presentation is usually subacute dementia, multiple
infarcts.
ESR of 20 (on one occasion ESR was 80 mm at 1st hr).
Intermittent red eye, anti GAD 65 antibody positive.
Ann Indian Acad Neurol 2006; 9: 240-8
Primary leptomeningeal neoplasm: diffuse leptomeningeal glioneuronal tumor
Points in favor Points against
Pure leptomeningeal disease Usually seen in children and adolescents.
Reported in 4th and 5th decades also No fever.
Indolent course over years. Usually complicated by hydrocephalus.
Very high CSF counts and neutrophils in CSF unlikely.
Patchy meningeal enhancement. Dural involvement.
Protein in CSF is markedly elevated.
Primary leptomeningeal melanoma: in slightly older patients, more rapid course as in
the above case report.
Final differential diagnosis
• Wegeners granulomatosis
• Neuro-sarcoidosis
• Cysticercal meningitis.
• ?MDR TB
Final diagnosis
Final diagnosis based on histopathology
• Chromoblastomycosis !!
• A common fungus found in the soil which can be inoculated into
the body by minor trauma.
• Infection with this fungi is very rare, can occur in
immunocompetent hosts and is usually very indolent.
• This patient responded to therapy with anti-fungal agents.
THANK YOU

More Related Content

What's hot

Withdrawal of anti epileptic drugs
Withdrawal of anti epileptic drugsWithdrawal of anti epileptic drugs
Withdrawal of anti epileptic drugsPramod Krishnan
 
Maintenance Electroconvulsive Therapy Augmentation on Clozapine-Resistant Psy...
Maintenance Electroconvulsive Therapy Augmentation on Clozapine-Resistant Psy...Maintenance Electroconvulsive Therapy Augmentation on Clozapine-Resistant Psy...
Maintenance Electroconvulsive Therapy Augmentation on Clozapine-Resistant Psy...Zahiruddin Othman
 
Pediatric migraine
Pediatric migrainePediatric migraine
Pediatric migrainesm171181
 
Status epilepticus and refractory status epilepticus
Status epilepticus and refractory status epilepticusStatus epilepticus and refractory status epilepticus
Status epilepticus and refractory status epilepticusSooraj Patil
 
Recent Advances in migraine
Recent Advances in migraine Recent Advances in migraine
Recent Advances in migraine DR ANUP PETARE
 
Choosing the right antiseizure medication for epilepsy
Choosing the right antiseizure medication for epilepsy  Choosing the right antiseizure medication for epilepsy
Choosing the right antiseizure medication for epilepsy Ersifa Fatimah
 
starting and continuing treatment in epilepsy
starting and continuing treatment in epilepsystarting and continuing treatment in epilepsy
starting and continuing treatment in epilepsysankalpgmc8
 
MG comparison, Ocular vs General
MG comparison, Ocular vs GeneralMG comparison, Ocular vs General
MG comparison, Ocular vs GeneralErsifa Fatimah
 
Headache – practical scenario
Headache – practical scenarioHeadache – practical scenario
Headache – practical scenariowebzforu
 
Principles of Antiepileptic therapy in focal epilepsy
Principles of Antiepileptic therapy in focal epilepsyPrinciples of Antiepileptic therapy in focal epilepsy
Principles of Antiepileptic therapy in focal epilepsyPramod Krishnan
 

What's hot (20)

Withdrawal of anti epileptic drugs
Withdrawal of anti epileptic drugsWithdrawal of anti epileptic drugs
Withdrawal of anti epileptic drugs
 
Maintenance Electroconvulsive Therapy Augmentation on Clozapine-Resistant Psy...
Maintenance Electroconvulsive Therapy Augmentation on Clozapine-Resistant Psy...Maintenance Electroconvulsive Therapy Augmentation on Clozapine-Resistant Psy...
Maintenance Electroconvulsive Therapy Augmentation on Clozapine-Resistant Psy...
 
Intractable seizure
Intractable seizureIntractable seizure
Intractable seizure
 
Pediatric migraine
Pediatric migrainePediatric migraine
Pediatric migraine
 
Final ppt epilepsy
Final ppt epilepsyFinal ppt epilepsy
Final ppt epilepsy
 
Status epilepticus and refractory status epilepticus
Status epilepticus and refractory status epilepticusStatus epilepticus and refractory status epilepticus
Status epilepticus and refractory status epilepticus
 
Recent Advances in migraine
Recent Advances in migraine Recent Advances in migraine
Recent Advances in migraine
 
Choosing the right antiseizure medication for epilepsy
Choosing the right antiseizure medication for epilepsy  Choosing the right antiseizure medication for epilepsy
Choosing the right antiseizure medication for epilepsy
 
Migraine
MigraineMigraine
Migraine
 
Refractory epilepsy
Refractory epilepsy Refractory epilepsy
Refractory epilepsy
 
Status Epilepticus
Status Epilepticus Status Epilepticus
Status Epilepticus
 
Refractory epilepsy
Refractory epilepsyRefractory epilepsy
Refractory epilepsy
 
Pharmacotherapy of migraine
Pharmacotherapy of migrainePharmacotherapy of migraine
Pharmacotherapy of migraine
 
starting and continuing treatment in epilepsy
starting and continuing treatment in epilepsystarting and continuing treatment in epilepsy
starting and continuing treatment in epilepsy
 
MG comparison, Ocular vs General
MG comparison, Ocular vs GeneralMG comparison, Ocular vs General
MG comparison, Ocular vs General
 
Headache – practical scenario
Headache – practical scenarioHeadache – practical scenario
Headache – practical scenario
 
Prof mizanur rahman choosing antiseizure drugs
Prof mizanur rahman choosing antiseizure drugsProf mizanur rahman choosing antiseizure drugs
Prof mizanur rahman choosing antiseizure drugs
 
Refractory epilepsy
Refractory epilepsy Refractory epilepsy
Refractory epilepsy
 
Principles of Antiepileptic therapy in focal epilepsy
Principles of Antiepileptic therapy in focal epilepsyPrinciples of Antiepileptic therapy in focal epilepsy
Principles of Antiepileptic therapy in focal epilepsy
 
Migraine
MigraineMigraine
Migraine
 

Similar to Clinico pathologic case conference 2019, Neurology

Orofacial physiotherapy in the management of dysphagia and dysphonia due to b...
Orofacial physiotherapy in the management of dysphagia and dysphonia due to b...Orofacial physiotherapy in the management of dysphagia and dysphonia due to b...
Orofacial physiotherapy in the management of dysphagia and dysphonia due to b...enweluntaobed
 
Giant cell arteritis,polymyalgia rheumatica
Giant cell arteritis,polymyalgia  rheumaticaGiant cell arteritis,polymyalgia  rheumatica
Giant cell arteritis,polymyalgia rheumaticaDoha Rasheedy
 
acute encephalitis syndrome
acute encephalitis syndromeacute encephalitis syndrome
acute encephalitis syndromeVijendrapatle1
 
Neuromyelitis Optica
Neuromyelitis OpticaNeuromyelitis Optica
Neuromyelitis OpticaArka De
 
Final project for Understanding Neurobiology in Everyday Life
Final project for Understanding Neurobiology in Everyday LifeFinal project for Understanding Neurobiology in Everyday Life
Final project for Understanding Neurobiology in Everyday LifeJhanviSolanki1
 
Meningitis.pptx
Meningitis.pptxMeningitis.pptx
Meningitis.pptxMeerub Ali
 
Idiopathic intracranial hypertension
Idiopathic intracranial hypertensionIdiopathic intracranial hypertension
Idiopathic intracranial hypertensionShruti Shirke
 
Running Head Clinical Diagnostic Zandria HamiltonMigr.docx
Running Head Clinical Diagnostic Zandria HamiltonMigr.docxRunning Head Clinical Diagnostic Zandria HamiltonMigr.docx
Running Head Clinical Diagnostic Zandria HamiltonMigr.docxtodd271
 
Homoeopathy and Migraine
Homoeopathy and MigraineHomoeopathy and Migraine
Homoeopathy and Migraineijtsrd
 
Lecture on Pediatric headache.pptx
Lecture on Pediatric headache.pptxLecture on Pediatric headache.pptx
Lecture on Pediatric headache.pptxMarthaBolanos
 
A case of acute encephalitis
A case of acute encephalitisA case of acute encephalitis
A case of acute encephalitisGnandas Barman
 
HEADACHE (CEPHAGIA).pptx
HEADACHE (CEPHAGIA).pptxHEADACHE (CEPHAGIA).pptx
HEADACHE (CEPHAGIA).pptxKomal Upreti
 
meningitis-170131181426888888888888.pptx
meningitis-170131181426888888888888.pptxmeningitis-170131181426888888888888.pptx
meningitis-170131181426888888888888.pptxDebdattaMandal5
 
Headache in Children.pptx
Headache in Children.pptxHeadache in Children.pptx
Headache in Children.pptxJwan AlSofi
 
Recent Migraine Headache Approach and Treatment.pptx
Recent Migraine Headache Approach and Treatment.pptxRecent Migraine Headache Approach and Treatment.pptx
Recent Migraine Headache Approach and Treatment.pptxSURENDRAKHOSYA2
 

Similar to Clinico pathologic case conference 2019, Neurology (20)

Orofacial physiotherapy in the management of dysphagia and dysphonia due to b...
Orofacial physiotherapy in the management of dysphagia and dysphonia due to b...Orofacial physiotherapy in the management of dysphagia and dysphonia due to b...
Orofacial physiotherapy in the management of dysphagia and dysphonia due to b...
 
Giant cell arteritis,polymyalgia rheumatica
Giant cell arteritis,polymyalgia  rheumaticaGiant cell arteritis,polymyalgia  rheumatica
Giant cell arteritis,polymyalgia rheumatica
 
Presentation diag dilemma
Presentation diag dilemmaPresentation diag dilemma
Presentation diag dilemma
 
acute encephalitis syndrome
acute encephalitis syndromeacute encephalitis syndrome
acute encephalitis syndrome
 
Dizziness1
Dizziness1Dizziness1
Dizziness1
 
Neuromyelitis Optica
Neuromyelitis OpticaNeuromyelitis Optica
Neuromyelitis Optica
 
Final project for Understanding Neurobiology in Everyday Life
Final project for Understanding Neurobiology in Everyday LifeFinal project for Understanding Neurobiology in Everyday Life
Final project for Understanding Neurobiology in Everyday Life
 
Headche
Headche  Headche
Headche
 
Meningitis.pptx
Meningitis.pptxMeningitis.pptx
Meningitis.pptx
 
Idiopathic intracranial hypertension
Idiopathic intracranial hypertensionIdiopathic intracranial hypertension
Idiopathic intracranial hypertension
 
Running Head Clinical Diagnostic Zandria HamiltonMigr.docx
Running Head Clinical Diagnostic Zandria HamiltonMigr.docxRunning Head Clinical Diagnostic Zandria HamiltonMigr.docx
Running Head Clinical Diagnostic Zandria HamiltonMigr.docx
 
Homoeopathy and Migraine
Homoeopathy and MigraineHomoeopathy and Migraine
Homoeopathy and Migraine
 
Casepres (1)
Casepres (1)Casepres (1)
Casepres (1)
 
Lecture on Pediatric headache.pptx
Lecture on Pediatric headache.pptxLecture on Pediatric headache.pptx
Lecture on Pediatric headache.pptx
 
A case of acute encephalitis
A case of acute encephalitisA case of acute encephalitis
A case of acute encephalitis
 
Headache
HeadacheHeadache
Headache
 
HEADACHE (CEPHAGIA).pptx
HEADACHE (CEPHAGIA).pptxHEADACHE (CEPHAGIA).pptx
HEADACHE (CEPHAGIA).pptx
 
meningitis-170131181426888888888888.pptx
meningitis-170131181426888888888888.pptxmeningitis-170131181426888888888888.pptx
meningitis-170131181426888888888888.pptx
 
Headache in Children.pptx
Headache in Children.pptxHeadache in Children.pptx
Headache in Children.pptx
 
Recent Migraine Headache Approach and Treatment.pptx
Recent Migraine Headache Approach and Treatment.pptxRecent Migraine Headache Approach and Treatment.pptx
Recent Migraine Headache Approach and Treatment.pptx
 

More from Pramod Krishnan

Epilepsy Management: Key issues and challenges
Epilepsy Management: Key issues and challengesEpilepsy Management: Key issues and challenges
Epilepsy Management: Key issues and challengesPramod Krishnan
 
Role of Biomarkers in Alzheimers Disease
Role of Biomarkers in Alzheimers DiseaseRole of Biomarkers in Alzheimers Disease
Role of Biomarkers in Alzheimers DiseasePramod Krishnan
 
Cannabidiol in Drug Resistant Epilepsy.pptx
Cannabidiol in Drug Resistant Epilepsy.pptxCannabidiol in Drug Resistant Epilepsy.pptx
Cannabidiol in Drug Resistant Epilepsy.pptxPramod Krishnan
 
Non epileptiform variants in EEG.pptx
Non epileptiform variants in EEG.pptxNon epileptiform variants in EEG.pptx
Non epileptiform variants in EEG.pptxPramod Krishnan
 
Activation Proceedures in EEG.pptx
Activation Proceedures in EEG.pptxActivation Proceedures in EEG.pptx
Activation Proceedures in EEG.pptxPramod Krishnan
 
Autoimmune Epilepsies.pptx
Autoimmune Epilepsies.pptxAutoimmune Epilepsies.pptx
Autoimmune Epilepsies.pptxPramod Krishnan
 
Painful Challenges in Neurology.pptx
Painful Challenges in Neurology.pptxPainful Challenges in Neurology.pptx
Painful Challenges in Neurology.pptxPramod Krishnan
 
Gut Microbiome and Multiple Sclerosis.pptx
Gut Microbiome and Multiple Sclerosis.pptxGut Microbiome and Multiple Sclerosis.pptx
Gut Microbiome and Multiple Sclerosis.pptxPramod Krishnan
 
Genetics in Epilepsy.pptx
Genetics in Epilepsy.pptxGenetics in Epilepsy.pptx
Genetics in Epilepsy.pptxPramod Krishnan
 
EEG in convulsive and non convulsive seizures in the intensive care unit
EEG in convulsive and non convulsive seizures in the intensive care unitEEG in convulsive and non convulsive seizures in the intensive care unit
EEG in convulsive and non convulsive seizures in the intensive care unitPramod Krishnan
 
Sleep Neurobiology and Insomnia.pptx
Sleep Neurobiology and Insomnia.pptxSleep Neurobiology and Insomnia.pptx
Sleep Neurobiology and Insomnia.pptxPramod Krishnan
 
Epilepsy in the Elderly.pptx
Epilepsy in the Elderly.pptxEpilepsy in the Elderly.pptx
Epilepsy in the Elderly.pptxPramod Krishnan
 
Dopamine agonists in advanced Parkinson’s disease.pptx
Dopamine agonists in advanced Parkinson’s disease.pptxDopamine agonists in advanced Parkinson’s disease.pptx
Dopamine agonists in advanced Parkinson’s disease.pptxPramod Krishnan
 
Clinical imaging and molecular biomarkers of drug resistant epilepsy.pptx
Clinical imaging and molecular biomarkers of drug resistant epilepsy.pptxClinical imaging and molecular biomarkers of drug resistant epilepsy.pptx
Clinical imaging and molecular biomarkers of drug resistant epilepsy.pptxPramod Krishnan
 
Broadest Spectrum ASMs.pptx
Broadest Spectrum ASMs.pptxBroadest Spectrum ASMs.pptx
Broadest Spectrum ASMs.pptxPramod Krishnan
 
Old vs New Antiseizure drugs.pptx
Old vs New Antiseizure drugs.pptxOld vs New Antiseizure drugs.pptx
Old vs New Antiseizure drugs.pptxPramod Krishnan
 
Treatment of epilepsy polytherapy vs monotherapy
Treatment of epilepsy polytherapy vs monotherapyTreatment of epilepsy polytherapy vs monotherapy
Treatment of epilepsy polytherapy vs monotherapyPramod Krishnan
 
Managing epilepsy in patients with comorbidities
Managing epilepsy in patients with comorbiditiesManaging epilepsy in patients with comorbidities
Managing epilepsy in patients with comorbiditiesPramod Krishnan
 
Women with Epilepsy: Role of newer anti-seizure drugs
Women with Epilepsy: Role of newer anti-seizure drugsWomen with Epilepsy: Role of newer anti-seizure drugs
Women with Epilepsy: Role of newer anti-seizure drugsPramod Krishnan
 

More from Pramod Krishnan (20)

Epilepsy Management: Key issues and challenges
Epilepsy Management: Key issues and challengesEpilepsy Management: Key issues and challenges
Epilepsy Management: Key issues and challenges
 
Role of Biomarkers in Alzheimers Disease
Role of Biomarkers in Alzheimers DiseaseRole of Biomarkers in Alzheimers Disease
Role of Biomarkers in Alzheimers Disease
 
Cannabidiol in Drug Resistant Epilepsy.pptx
Cannabidiol in Drug Resistant Epilepsy.pptxCannabidiol in Drug Resistant Epilepsy.pptx
Cannabidiol in Drug Resistant Epilepsy.pptx
 
Non epileptiform variants in EEG.pptx
Non epileptiform variants in EEG.pptxNon epileptiform variants in EEG.pptx
Non epileptiform variants in EEG.pptx
 
Artifacts in EEG.pptx
Artifacts in EEG.pptxArtifacts in EEG.pptx
Artifacts in EEG.pptx
 
Activation Proceedures in EEG.pptx
Activation Proceedures in EEG.pptxActivation Proceedures in EEG.pptx
Activation Proceedures in EEG.pptx
 
Autoimmune Epilepsies.pptx
Autoimmune Epilepsies.pptxAutoimmune Epilepsies.pptx
Autoimmune Epilepsies.pptx
 
Painful Challenges in Neurology.pptx
Painful Challenges in Neurology.pptxPainful Challenges in Neurology.pptx
Painful Challenges in Neurology.pptx
 
Gut Microbiome and Multiple Sclerosis.pptx
Gut Microbiome and Multiple Sclerosis.pptxGut Microbiome and Multiple Sclerosis.pptx
Gut Microbiome and Multiple Sclerosis.pptx
 
Genetics in Epilepsy.pptx
Genetics in Epilepsy.pptxGenetics in Epilepsy.pptx
Genetics in Epilepsy.pptx
 
EEG in convulsive and non convulsive seizures in the intensive care unit
EEG in convulsive and non convulsive seizures in the intensive care unitEEG in convulsive and non convulsive seizures in the intensive care unit
EEG in convulsive and non convulsive seizures in the intensive care unit
 
Sleep Neurobiology and Insomnia.pptx
Sleep Neurobiology and Insomnia.pptxSleep Neurobiology and Insomnia.pptx
Sleep Neurobiology and Insomnia.pptx
 
Epilepsy in the Elderly.pptx
Epilepsy in the Elderly.pptxEpilepsy in the Elderly.pptx
Epilepsy in the Elderly.pptx
 
Dopamine agonists in advanced Parkinson’s disease.pptx
Dopamine agonists in advanced Parkinson’s disease.pptxDopamine agonists in advanced Parkinson’s disease.pptx
Dopamine agonists in advanced Parkinson’s disease.pptx
 
Clinical imaging and molecular biomarkers of drug resistant epilepsy.pptx
Clinical imaging and molecular biomarkers of drug resistant epilepsy.pptxClinical imaging and molecular biomarkers of drug resistant epilepsy.pptx
Clinical imaging and molecular biomarkers of drug resistant epilepsy.pptx
 
Broadest Spectrum ASMs.pptx
Broadest Spectrum ASMs.pptxBroadest Spectrum ASMs.pptx
Broadest Spectrum ASMs.pptx
 
Old vs New Antiseizure drugs.pptx
Old vs New Antiseizure drugs.pptxOld vs New Antiseizure drugs.pptx
Old vs New Antiseizure drugs.pptx
 
Treatment of epilepsy polytherapy vs monotherapy
Treatment of epilepsy polytherapy vs monotherapyTreatment of epilepsy polytherapy vs monotherapy
Treatment of epilepsy polytherapy vs monotherapy
 
Managing epilepsy in patients with comorbidities
Managing epilepsy in patients with comorbiditiesManaging epilepsy in patients with comorbidities
Managing epilepsy in patients with comorbidities
 
Women with Epilepsy: Role of newer anti-seizure drugs
Women with Epilepsy: Role of newer anti-seizure drugsWomen with Epilepsy: Role of newer anti-seizure drugs
Women with Epilepsy: Role of newer anti-seizure drugs
 

Recently uploaded

97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAAjennyeacort
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxNiranjan Chavan
 
call girls in Connaught Place DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...
call girls in Connaught Place  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...call girls in Connaught Place  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...
call girls in Connaught Place DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...saminamagar
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfDolisha Warbi
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptxDr.Nusrat Tariq
 
See the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformSee the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformKweku Zurek
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptxTina Purnat
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt downloadAnkitKumar311566
 
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...saminamagar
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxGlomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxDr.Nusrat Tariq
 
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Prerana Jadhav
 
Report Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxReport Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxbkling
 

Recently uploaded (20)

Epilepsy
EpilepsyEpilepsy
Epilepsy
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
 
call girls in Connaught Place DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...
call girls in Connaught Place  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...call girls in Connaught Place  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...
call girls in Connaught Place DELHI 🔝 >༒9540349809 🔝 genuine Escort Service ...
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptx
 
See the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy PlatformSee the 2,456 pharmacies on the National E-Pharmacy Platform
See the 2,456 pharmacies on the National E-Pharmacy Platform
 
The next social challenge to public health: the information environment.pptx
The next social challenge to public health:  the information environment.pptxThe next social challenge to public health:  the information environment.pptx
The next social challenge to public health: the information environment.pptx
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt download
 
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in aerocity DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxGlomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptx
 
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in munirka  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in munirka DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.Presentation on General Anesthetics pdf.
Presentation on General Anesthetics pdf.
 
Report Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxReport Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptx
 

Clinico pathologic case conference 2019, Neurology

  • 1. Clinico pathologic conference Bengaluru Neurological Society Presenter: Dr Pramod Krishnan Consultant Neurologist Manipal Hospital, Bengaluru
  • 3. Chief complaints • 48yr/ male, farmer from West Bengal. • Apparently normal till January 2017. Since then: 1. Holocranial throbbing headache 2. Mild intermittent fever 3. Bilateral painless impairment in vision (April 2017)
  • 4. History of presenting illness: fever • First seen at NIMHANS on 13.05.17. • Fever from January 2017, mild, intermittent, and usually in the form of an evening rise of temperature. • The fever used to subside with anti-pyretics with mild sweating. There were no chills or rigors.
  • 5. Headache • Headache was holocranial, worse in the occipital and neck region. • It was intermittent and throbbing in nature. • It was not associated with vomiting. • There was no specific diurnal or postural change.
  • 6. Impairment of vision • From April 2017, developed bilateral painless impairment in vision. • It was worse in the right as compared to the left eye. • The onset was not clear, but there was no progression from the time it was noted. • There was intermittent redness of the eyes (? no pain). • There was no excessive lacrimation or diplopia.
  • 7. History of presenting illness • No symptoms referable to other cranial nerves or limbs. • No band-like sensation, inco-ordination of limbs, involuntary movements, cognitive decline, seizures or altered sensorium. • No history of skin rash, pain or swelling of joints, photosensitivity, muco-cutaneous ulcers, diabetes mellitus or hypertension. • No significant past medical history.
  • 8. Personal and family history • Mixed diet • No change in appetite or weight loss. • No substance use. • He had contact with cattle, but denied handling placental products or raw milk. • No family history of tuberculosis.
  • 9. Treatment history • He was diagnosed as TBM at another centre and was on treatment from 6th May 2017 (HRZE and 20mg/d prednisolone).
  • 11. Fever • Fever, low grade, lasting 5 months is most likely due to inflammatory conditions (infectious, non-infectious) but may occur with non-inflammatory conditions like neoplasms. • No significant systemic symptoms or weight loss.
  • 12. Headache • Headache since 5 months is diffuse, poorly localised, persistent, and consistent with a secondary headache. • To consider an intracranial pathology in view of the poorly localised deep seated pain. • Cause could be inflammation, raised ICP or lesions causing stretch, compression, or infiltration of pain-sensitive structures.
  • 13. Headache • No history to suggest raised ICP as the cause of headache, such as pain worse on awakening, coughing/straining, activity, or associated vomiting, tinnitus, dizziness, TVO. • Headache is worse in the occipital and neck region, indicating involvement of posterior fossa structures, meninges. • Meningeal pathology causes non-localising headache, with or without raised ICP features.
  • 14. Visual impairment • Bilateral (asymmetric) painless loss of vision (non-progressive): 1. Bilateral optic neuropathies: inflammatory, ischemic, toxic. 2. Papilledema 3. Lesions of optic chiasma, less often, optic tracts. 4. Occipital stroke, bilateral 5. Pituitary apoplexy. 6. Trauma 7. Functional visual loss.
  • 15. Causes of Red eye Remarks Corneal abrasions Trauma, Vth or VIIth nerve palsy. Subconjunctival hemorrhage Spontaneous, trauma, coughing, bleeding diathesis. Pingueculitis Inflammation of pinguecula, a small, raised nodule at the temporal or nasal limbus. Dacryocystitis Obstruction of the lacrimal system. Conjunctivitis Infectious (viral, allergic). Keratitis Trachoma, HSV, VZV, other bacterial and fungal infection, Vit A def. Keratoconjunctivits sicca Drugs, Sarcoidosis, Sjogren, radiation, VIIth nerve palsy. Episcleritis Idiopathic > autoimmune. Scleritis Usually autoimmune: RA, SLE, PAN, Wegeners, relapsing polychondritis. Anterior uveitis (iridocyclitis) Sarcoidosis, AS, JRA, IBD, psoriasis, Reiter’s, Behcets, TB, leprosy, Lymes, syphilis, herpes, onchocerciasis. Posterior uveitis Sarcoidosis, Behcets, VGH, IBD, bacterial, fungal, spirochetal and mycobacterial infections. Endophthalmitis Bacterial, fungal, viral, parasitic infections. Acute angle closure glaucoma
  • 16. Provisional diagnosis 1. Chronic infectious meningitis: TB, Brucella, fungal 2. Chronic non-infectious meningeal inflammation: vasculitis 3. Slowly progressive diffuse intracranial neoplasm. • Raised ICP due to either of these pathologies to be considered. • Wide range of infectious etiology to be considered as patient could be immunocompromised.
  • 17. Clinical examination • He was conscious, alert, and oriented. • General physical examination was normal. • Visual acuity was 6/9 and 6/12 in the right and left eyes respectively. • Optic fundi were normal. Other cranial nerves were normal. • Motor system, sensory system, DTRs, were normal. • Plantar response was flexor bilaterally. • There were no meningeal signs.
  • 18. Analysis • No papilledema, therefore headache and visual impairment is unlikely due to raised ICP. • Bilateral visual impairment with normal fundi and EOMS indicates inflammatory, infiltrative or ischemic pathology involving optic chiasma/ optic nerves.
  • 19. Provisional diagnosis • Structures involved: 1. Meninges 2. Optic chiasma and adjoining posterior portions of both the optic nerves/ tracts. 3. ?Uveitis/ keratoconjnctivitis • Pathology: 1. Chronic infectious meningitis 2. Chronic non-infectious meningeal inflammation 3. Slowly progressive diffuse intracranial neoplasm.
  • 20. Uveo-meningitis Sarcoidosis Primary angiitis of CNS. Vogt-Koyanagi-Harada syndrome Syphilis Primary CNS lymphoma Lyme disease Behcets syndrome HTLV type 1 infection SLE Acute multifocal placoid pigmentary epitheliopathy
  • 21. Course of his illness
  • 22. CSF analysis (done elsewhere) • Confirms meningeal pathology, most likely inflammation. • 5 months into his illness, protein elevation is mild (unusual for TB and other infections), with lymphocytic pleocytosis. • Primary leptomeningeal neoplasm can mimic tuberculosis. Parameter May 17* Appearance Cell count (/cu mm) 102 Cell type L- 70% P- 30% CSF protein (mg/dl) 74 CSF glucose (mg/dl) 42 CSF Chloride (mmol/L) NA CSF Lactate (mg/dl) NA Gram stain India Ink NA Cryptococcal Ag Bacterial culture AFB culture
  • 23. Course of his illness • In view of visual impairment, ATT was modified. • Ethambutol was stopped and streptomycin (750 mg/ day, IM) and ofloxacin (800 mg/ day) were introduced. • The dose of oral prednisolone was increased to 60 mg/ day.
  • 25. Course of his illness • Fever subsided from June 2017. • Headache reduced partially. There was minimal change in vision. • Developed impaired hearing in the left ear from June 2017. • There was no local pain, swelling or ear discharge. • AC > BC in the right ear, and Weber’s test showed lateralisation to the right ear; the patient could not perceive the sound of the tuning fork by air or bone conduction in the left ear (left SNHL). • There were no other new neurological deficits.
  • 26. Comment • Improvement in headache and fever could be due to ATT, or more likely due to steroids. • Inspite of therapy, vision did not improve and he developed left sided sensori neural deafness, suggesting left VIIIth nerve involvement.
  • 28. Parameter May 17* Aug 2017 Appearance Clear Cell count (/cu mm) 102 115 Cell type L- 70% P- 30% L- 70% P- 29% Degenerative cells 1% CSF protein (mg/dl) 74 47 CSF glucose (mg/dl) 42 47 CSF Chloride (mmol/L) NA NA CSF Lactate (mg/dl) NA NA Gram stain India Ink NA Negative Cryptococcal Ag Bacterial culture AFB culture No growth Parameter May 17 Aug 2017 Gene Xpert Cytospin Transformed lymphocytes, admixed with reactive monocytes and RBCs. Few PMN cells are also seen VDRL Non-reactive Xcyton panel CSF Analysis No significant improvement except for drop in protein levels.
  • 29. Course of his illness • Streptomycin and pyrazinamide were discontinued in August 2017. Isoniazid, rifampicin and ofloxacin were continued along with oral prednisolone (60 mg/day). • He also developed cushingoid facies by August 2017.
  • 31. Course of the illness • Recurrence of fever from November 2017, which was mild, intermittent and usually in the morning. This was not associated with night sweats, loss of appetite or weight loss. • Headache increased in frequency and intensity, was frontal in location and used to resolve spontaneously in 5 to 10 minutes. • He also developed diabetes mellitus which was treated.
  • 32. 2018
  • 33. Course of his illness • Isoniazid, rifampicin and ofloxacin were continued. • Prednisolone was tapered from January 2018 by 5 mg every 15 days to 5 mg/ day by July 2018. • The patient developed neck pain from mid-July 2018 along with left hemicranial headache. • Isoniazid and rifampicin were continued. Ofloxacin was discontinued in November 2018.
  • 34. 2019
  • 35. Course of his illness • Ethambutol (800 mg/ day) and Moxifloxacin (400 mg/ day) were added. • Oral prednisolone was increased to 60 mg/ day. • However, there was progressive increase in headache, mainly in the neck and vertex region. • Hence he underwent biopsy of meninges on 14th March 2019. • Based on the biopsy he was initiated on treatment. He was discharged on 20th March 2019. There is no further follow up.
  • 36. Test 27/July/17 12/Nov/18 28/Feb/19 13/Mar/19 14/Mar/19 16/Mar/19 Hb (ref: 13-17 gm/dl) 15.4 16.0 14.1 Haematocrit (ref: 40-50%) 45.2% MCH (ref: 27-32 pg) 30.5 MCHC (31.5-34.5 g/dl) 34.0 MCV (ref: 83-101 fl) 89.7 TLC (ref: 4-11K/ µl) 10.5 13.4 11.4 Differential count N=52.2%, L=36.3%, M=6.3%, E=4.8%, B=0.4% N=75.2%, L=14.1%, M=9.4%, E=0.4%, B=0.9% Platelets (ref: 150-450K/µl) 82 207 207 ESR (ref: 0-10 mm/hr) 9 20 20 80 Peripheral smear Normal except for several large platelets seen. No hemoparasites. Hematology
  • 37. Tests 27/July/17 30/ Jan/ 18 5/ Nov/ 18 28/ Feb/ 19 13/ Mar/ 19 14/ Mar/ 19 RBS (mg/dl) (ref: 70-140 mg/ dL) 90 324 70 FBS (mg/dl) (ref: 70-100 mg/ dL) 161 PPBS (mg/dl) (ref: 100-140 mg/dl) 322 Urea (mg/dl) 15 16 18.0 20.0 Creatinine (mg/dl) 0.91 0.78 0.8 0.8 T Protein (g/dL) (ref: 5.7-8.0 g/ dL) 6.6 6.20 6.60 Albumin (g/dL) (ref: 3.5-5.2 g/ dL) 3.86 4.00 3.90 Globulin (g/dL) (ref: 2.5-5.6 g/ dL) 2.7 2.20 2.70 A:G Ratio (ref: 1.2-2.5) 1.4 1.80 1.40 Total Bilirubin (mg/dl) 0.90 0.34 0.75 ALP (U/L) (ref: 52-171 U/ L) 106 102 70 SGOT (U/L) (ref: 8-50 U/ L) 92 14.0 33.0 SGPT (U/L) (ref: 7-50 U/ L) 240 30.0 36.0 Sodium (mEq/L) 139.4 141.00 140.0 137.2 Potassium (mEq/L) 4.21 3.92 4.18 3.82 Chloride (mEq/L) 100.2 98 104.2 107.2 Homocysteine (ref:<15micromol/L) 12.9 Vitamin B12 (ref: 197-771 pg/ml) 257 Biochemistry
  • 38. Parameter May 17* Aug 2017 Sept 2018 Nov 18 Jan 2019 Mar 2019 Appearance Clear Clear Hazy Slightly hazy Cell count (/cu mm) 102 115 350 140 1000 120 Cell type L- 70% P- 30% L- 70% P- 29% Degenerative cells 1% L- 80% Degenerated cells- 20% Occasional RBCs L- 70% P- 30% L- 20% P- 80% Occasional RBCs L- 20% P- 75% Degenerative cells 5% CSF protein (mg/dl) 74 47 155 105 338 177 CSF glucose (mg/dl) 42 47 73 175 297 216 CSF Chloride (mmol/L) NA NA 120 119 114 119 CSF Lactate (mg/dl) NA NA NA 28 NA NA Gram stain Pus cells. No bacteria Pus cells. No bacteria India Ink NA Negative Negative NA Negative Negative Cryptococcal Ag Negative Bacterial culture No growth AFB culture No growth No growth No growth CSF analysis * reported from another centre.
  • 39. Parameter May 17 Aug 2017 Sept 2018 Nov 18 Jan 2019 Mar 2019 Gene Xpert Insufficient sample Negative Negative Cytospin Transformed lymphocytes, admixed with reactive monocytes and RBCs. Few PMN cells are also seen Transformed lymphocytes, few reactive monocytes, PMN cells & RBC's. Predominantly PMN cells, few lymphocytes, occasional reactive monocytes, eosinophils & plasmacytoid cells. Numerous degenerating PMN cells, few intermixed reactive lymphocytes and monocytoid cells. VDRL Non-reactive Non-reactive Xcyton panel Positive for cysticercal antibody CSF analysis
  • 40. Chronic meningitis with neutrophilis in CSF Infections Non-infectious Tuberculosis SLE Brucella Chemical meningitis: craniopharyngioma Nocardia asteroides Adult Stills disease Actinomyces israeli Primary CNS angiitis. Cysticercal meningitis Fungi: Blastomyces dermatitidis, Candida albicans, Histoplasma capsulatum, Aspergillus spp, Pseudallescheria boydii, Cladophialophora bantiana.
  • 41. Cysti-CheX test for cysticercosis (Xcyton) • Semi-quantitative ELISA for detecting antibodies to cysticercal E- S antigens. • It uses Secretory and Excretory antigens of cysticerci (E-S antigen). • These antigens are very specific and immunogenic. • Sensitivity and specificity of the test is close to 100% (Neurological practice: an Indian perspective. 2015. Ed Noshir H Wadia, Satish V Khadilkar)
  • 42. Other investigations Results TFT Normal ANA, ANA profile, ANCA, RA Negative ACE level Normal PT, APTT Normal HIV, S. VDRL Non reactive Blood culture No growth HbA1c 8.8% (Jan 2018), 15.6% (March 2019) Serum paraneoplastic antibody panel GAD65 positive (1+) Brucella Standard Agglutination Test Negative Absolute CD4 count 1856 /ul
  • 43. Anti GAD 65 positivity Stiff person syndrome Hashimotos thyroiditis Autoimmune encephalitis Pernicious anemia Brain stem encephalitis Type 1 diabetes. Cerebellar ataxia syndromes Myelitis Myasthenia gravis Miller Fischer syndrome like presentation Lambert Eaton syndrome Autoimmune encephalitis Positive GAD 65 antibody may suggest an autoimmune process in this patient.
  • 44. Audiometry (23/8/17): right ear normal. Left ear shows severe sensori neural deafness. July 2017 November 2018 Right eye Inferior altitudinal scotoma Normal Left eye Normal Normal Visual field charting: VEP: P100 latency- 107.7 ms (Rt), 106.5 ms (lt): upper limit of normal. SSEP of median and posterior tibial nerves: Normal BAER I II III IV V I-III III-V I-V Right ear 1.45 2.76 3.74 4.98 5.96 2.29 2.22 4.51 Normal Left ear 2.39 5.57 7.13 4.74 Delayed.
  • 46. MRI brain 3D post-contrast T1W axial sequence shows few enhancing nodules along tentorium and meninges.
  • 47. MRI brain post contrast T1W axial sequence shows dural enhancement along prepontine cistern and seventh nerve in left IAC (left) and focal enhancing nodule along pial surface of medulla (right).
  • 48. MRI upper cervical cord post contrast T1W sequence axial (left) and sagittal (right) showing tiny enhancing foci along surface of cervical cord.
  • 49. MRI brain post contrast T2flair axial sequences show lepto-meningeal enhancement in the basal cisterns.
  • 51. MRI cervical spine coronal and axial post contrast of cervical spine shows nodular dural enhancement in upper cervical cord on right side .There is also enhancement along left cervical nerve roots.
  • 52. MRI brain post contrast T1W axial sequence shows Persistence of dural enhancement along pre- pontine cistern and left seventh nerve.
  • 53. MRI brain post contrast T1W axial sequence shows leptomeningeal enhancement along lateral and posterior surface of brainstem.
  • 54. MRI brain post contrast flair shows increased leptomeningeal enhancement in basal cisterns and interval appearance of leptomeningeal enhancement in right posterior Sylvian fissure.
  • 55. MRI brain fiesta images shows right half of chiasm, optic tract showing increased signal. There is also absent CSF plane with adjacent structures ? Septations. No post contrast enhancement.
  • 56. Summary of MRI images • Leptomeningeal nodular patchy enhancement involving basal cisterns, optic chaisma and around the cervical cord and roots, with adhesions. • No parenchymal involvement at the end of 2 years. • Small areas of dural involvement noted in the cervico medullary junction. • Definite increase in lesions while on treatment. • Possibilities are granulomatous leptomeningeal disease > primary leptomeningeal neoplasm.
  • 57. Other radiological investigations • CT thorax (twice): unremarkable. • CT brain: unremarkable. No calcification. • X ray chest: unremarkable. • X ray cervical spine: unremarkable. • USG abdomen: normal.
  • 59. Summary • Chronic meningeal disease of > 2 years duration, with fever. • No response to ATT, clinically or based on CSF, MRI. • Partial benefit with steroids, with worsening on steroid reduction, but some worsening occurred while on 60 mg/d prednisolone. • Nodular patchy leptomeningeal enhancement on MRI involving basal cisterns, surface of medulla and cervical cord, roots, sylvian fissure, with dural involvement and adhesions and without parenchymal involvement. • CSF shows lymphocytic pleocytosis with mild elevation of proteins and later shows predominance of PMNs and counts >1000 cells.
  • 60. Bacterial and parasitic infections Disease Points in favour Points against Tuberculosis Neutrophilic CSF pleocytosis can occur, (but usually early in the disease). Leptomeningeal disease of 2 years with fever and headache can occur. ?MDR TB. No parenchymal involvement. No systemic symptoms. No response to ATT Gene X pert repeatedly negative Only mild elevation of CSF protein Cysticercal meningitis Xcyton cysticercal test positive in CSF. Partial response to steroids. Involvement of basal cisterns, adhesions. Neutrophils in CSF and cell count of >1000 are described in this condition. No cysts seen in the basal cisterns. No CSF pathway obstruction seen.
  • 61. • 138/336 pts (41%) had parasites in the subarachnoid space at the base of the brain. • Group A had a mean ± SD disease duration of 36.33 ± 13.4 months, and Group B had a mean ± SD disease duration of 15.6 ± 1.91 months. • Group A had increased neutrophils with a mean ± SD of 2,158 ± 475.78 cells/cumm.
  • 62. 14 patients in this series presented as chronic meningitis.
  • 63. Clinical Infectious Diseases 2013;56(10):1407–12 The sensitivity of tube agglutination (TA) in CSF was 0.94, specificity 0.96, positive predictive value 0.94, and negative predictive value 0.96. Points in favor Points against Rifampicin, Streptomycin are effective treatment for Brucellosis No musculoskeletal disease or brain parenchymal disease at the end of 2 years. Can present as chronic meningitis. Brucella antibody test is negative h/o contact with cattle. CSF cell count of 1000 is not reported. Neutrophils in CSF may be seen.
  • 64. Chronic fungal/ Nocardia meningitis • Some of these organisms are ubiquitous and endemic in parts of India, but others are very rarely reported. • CSF neutrophils can be seen. • However, more common in immunocompromised patients. • No appropriate exposure history. • Absence of brain parenchymal lesions, parameningeal focus, sino- pulmonary disease over 2 years, while on steroids is odd. • Usually cause complicated meningitis.
  • 65. Wegeners granulomatosis Points in favour Points against Nodular leptomeningeal enhancement. Dural involvement. Isolated CNS disease is possible. Intermittent red eye. CSF can show neutrophils Poor response to steroids alone is possible as it requires aggressive immunosuppression. No sinus or pulmonary disease. Usually causes pachymeningitis. ANCA negative. CSF cell count of 1000 is rare.
  • 66. Neurosarcoidosis Points in favour Points against Isolated neurosarcoidosis is well known. Cranial neuropathy (II, VIII). Partial response to steroids. Possible uveitis (red eye). CT thorax normal (twice). ACE levels normal. CSF neutrophils not reported. Steroids are the mainstay of treatment, so response should have been better. CSF cell count of 1000 is unlikely.
  • 67. • 10/91 patients with neurosarcoidosis had isolated neuro-sarcoidosis. • Common clinical manifestations: headache (9), paresthesia (5), and cranial neuropathies (4). • No extraneural sarcoidosis developed during a long follow-up period (mean 58 mo). • Compared with those who also had systemic neurosarcoidosis, isolated neurosarcoidosis patients had a more common frequency of headache, hemiparesis, and radiculopathy, leptomeningeal involvement on brain MRI, increased cell count in cerebrospinal fluid, and a more favorable clinical outcome (P < 0.05). The Neurologist 2012; 18:373–377)
  • 68. Disease Points in favour Points against SLE, Sjogrens CSF neutrophils is reported. Possible uveitis. ANA, ANA profile negative. Very high cell counts is not reported. Absence of brain parenchymal disease or systemic disease. Inadequate response to steroids. Behcets disease Possible uveitis. Usually a recurrent meningitis. No oro-genital ulcers. CSF neutrophils, very high cell counts not reported. SLE, Behcets disease, Primary CNS angiitis Primary CNS angiitis is unlikely as the presentation is usually subacute dementia, multiple infarcts. ESR of 20 (on one occasion ESR was 80 mm at 1st hr). Intermittent red eye, anti GAD 65 antibody positive.
  • 69. Ann Indian Acad Neurol 2006; 9: 240-8 Primary leptomeningeal neoplasm: diffuse leptomeningeal glioneuronal tumor Points in favor Points against Pure leptomeningeal disease Usually seen in children and adolescents. Reported in 4th and 5th decades also No fever. Indolent course over years. Usually complicated by hydrocephalus. Very high CSF counts and neutrophils in CSF unlikely. Patchy meningeal enhancement. Dural involvement. Protein in CSF is markedly elevated. Primary leptomeningeal melanoma: in slightly older patients, more rapid course as in the above case report.
  • 70. Final differential diagnosis • Wegeners granulomatosis • Neuro-sarcoidosis • Cysticercal meningitis. • ?MDR TB
  • 72. Final diagnosis based on histopathology • Chromoblastomycosis !! • A common fungus found in the soil which can be inoculated into the body by minor trauma. • Infection with this fungi is very rare, can occur in immunocompetent hosts and is usually very indolent. • This patient responded to therapy with anti-fungal agents.